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Dr David L. Morales (Cincinnati, Ohio). Sam, I want to
congratulate you on a wonderful presentation and really all the au-
thors on an article that will serve as a great reference to our spe-
cialty and growing interest in VAD therapy in children.
Now, the inability to support stage I patients with a VAD really
highlights the use of salvage VADs, which are VADs used after an
unsuccessful palliation, with these patients subsequently going to
ECMO then a VAD. This type of patient has been shown repeat-
edly in many studies to have extremely poor results regardless of
a single-ventricular or a biventricular physiology. Trying to
salvage a failed Norwood is just the extreme example of salvage
VADs, and it is why their outcomes here are so poor with 89%
mortality.
I have 3 questions regarding this group.
Of the stage I patients who were supported during the neonatal
period, how many were on ECMO then a VAD or on a VAD
switched to ECMO?
The second question is: What was the time from operation to
VAD for the stage I group?
And 3, was any Norwood discharged from the intensive care
unit or home before moving to a VAD?
DrWeinstein. David, thank you very much for your comments
and your questions. Your expertise in this field is well recognized,
and I have greatly appreciated your advice and personal insight as
we have established our own assistance program at my institution.
Four of the 5 neonates who had a VAD implanted were patients
who were already on ECMO. There was 1 neonate whose first sur-
gery was an LVAD and a BT shunt, but this patient was converted704 The Journal of Thoracic and Cardiovascular Surgto ECMO in the operating room for failure to support the cardiac
circulation. All stage I patients in this review regardless of age
were on ECMO before placement of the device.
Unfortunately, we do not have the information on previous sur-
geries or discharge data. However, regarding the patients who had
a VAD implanted within 30 days of life, I think we can infer that
their palliative procedures, ECMO, and subsequent VAD were
all in close proximity. As well, there were 3 stage I patients who
were aged 7 months, 8 months, and 17 months at the time of
VAD implantation, and it may also be inferred that some of these
patients were discharged home or at least achieved some form of
stability before placement of their mechanical assist device.
Dr Morales. Even with the Glenn cohort, a Glenn who fails in
the first few days after surgery is much different than a Glenn who
goes home and comes back with a failing systemic ventricle. The
Glenn that goes home and returns should be able to be successfully
supported, where the one that immediately fails in the intensive
care unit again is a salvage VAD and probably would not do
well. So with regard to this group, what was the time from Glenn
to VAD for survivors and nonsurvivors?
And 2, did any of the Glenns go home and return for their VAD,
and what was their survival compared with thosewho never left the
hospital?
DrWeinstein. The Berlin Heart database does not have the data
on the timing of any procedures performed before the VAD, but the
median age of patients undergoing a VAD implant with Glenn
shunt physiology was 2 years, and the oldest patient was 13 years.
For similar reasons, I assume several of these patients left the hos-
pital, some for perhaps a significant amount of time. So I think that
these data support your presumption that the further out you are
from any one of your staged palliations, the more likely you are
to survive VAD support.
Dr Morales. And just a final comment. Single-ventricle pa-
tients are not different than other congenital patients and a failed
palliation supported with a VAD will probably result in poor out-
comes; however, the single-ventricle physiology just emphasizes
this point.
Having said that, VAD therapy in patients who have systemic-
to-pulmonary shunt and the late-failing Fontan are unique chal-
lenges compared with other single-ventricle patients and ones
that we will have to continue to investigate I think. But again,
you and your authors have given us a great first step with this
article. Thank you.
Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
Sam, could you comment a little bit on the overall interpretation
of your presentation. I mean, it sounds quite dismal in terms of
the concept of mechanical support for the failing single ventricle,
but that may be a function of some immutable bit of physiology
among single-ventricle patients or it may be that we are just too
slow to pull the trigger and go to mechanical support. This is a de-
cision we wrestle with constantly. And can you get any insights
from the data that you have here?
Dr Weinstein. I think that success is related as much to age as
to stage, and I am not sure which variable is the most important.
There were 4 patients who were supported with ECMO before
VAD implantation who were not shunted patients, 2 Glenns
and 2 Fontans. And 3 of those 4 survived. So I think that for ne-
onates and for shunted patients, and as a salvage procedure, itery c February 2014
Weinstein et al Congenital Heart Diseasedoes not seem, from this small group only, that it would be war-
ranted. But I do think for older patients, patients that may be
further out from stage II or stage III palliation, it is very much
worth considering.
Dr Pedro J. del Nido (Boston, Mass). Do you have any infor-
mation about, especially focusing on the neonatal group, the
need for CPR before any mechanical support, either ECMO or ifThe Journal of Thoracic and Cayou went straight to a VAD? Do you have any data about that
group? Because I would think that need for CPRmay be the trigger
point for you to decide whether you are going to put a child on this
long-term assist or not.
DrWeinstein. That is an excellent point. Unfortunately, the in-
formation about CPR or other status before ECMO implant is
anecdotal.rdiovascular Surgery c Volume 147, Number 2 705
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